Nyxoah NYXH
NASDAQ NYXH
$1.40 -0.08 (-5.41%)
At close: Sep 22, 2026 · 4:00 PM EDT

Nyxoah (NYXH) Consolidated Net Income (2021 - 2026)

Nyxoah (NYXH) posted Consolidated Net Income of -$37.2 million for Q2 2026, down 299.33% on a QoQ basis from $18.7 million in Q1 2026, and down 63.93% year-over-year from -$103.2 million in Q2 2025.

Analysis

Nyxoah (NYXH) Consolidated Net Income (2021 - 2026) Analysis & Trends

Nyxoah has reported Consolidated Net Income for 6 years, with the latest figure at -$37.2 million in Q2 2026.

  • On a quarterly basis, Consolidated Net Income fell 63.93% year-over-year to -$37.2 million in Q2 2026; TTM through Jun 2026 was -$72.1 million, a 129.64% decrease from a year earlier, with the FY2025 full-year figure at $101.8 million, up 58.75% from the prior year.
  • Consolidated Net Income was -$37.2 million for Q2 2026 at Nyxoah, down from $18.7 million in the prior quarter.
  • The five-year high for Consolidated Net Income was $23.5 million in Q1 2025, with the low at -$37.2 million in Q2 2026.
  • Average Consolidated Net Income over 5 years is -$9.4 million, with a median of -$12.6 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2025: Consolidated Net Income slumped 1193.18% in 2022, then surged 285.47% in 2025.
  • Over 5 years, Consolidated Net Income stood at -$12.0 million in 2022, then fell by 3.92% to -$12.4 million in 2023, then retreated by 11.74% to -$13.9 million in 2024, then slumped by 82.18% to -$25.3 million in 2025, then slumped by 47.14% to -$37.2 million in 2026.
  • The last three Consolidated Net Income figures came in at -$37.2 million (Q2 2026), $18.7 million (Q1 2026), and -$25.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Abbott Laboratories 178.18 Bn 173.23 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 142.14 Bn 137.06 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.43 Bn 109.23 Bn 6.34 Bn 1.48 Bn
4 Stryker 105.15 Bn 101.68 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 63.37 Bn 63.08 Bn 3.85 Bn 905.00 Mn
6 Edwards Lifesciences 50.93 Bn 46.79 Bn 1.35 Bn 241.40 Mn
7 Dexcom 33.65 Bn 31.71 Bn 830.00 Mn 249.10 Mn
8 Resmed 32.27 Bn 30.80 Bn 861.22 Mn 383.43 Mn
9 Alcon 31.62 Bn 30.17 Bn 1.68 Bn -92.00 Mn
10 Nyxoah 63.68 Mn -49.98 Mn 5.33 Mn -37.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -37.21 Mn
Mar 31, 2026 18.67 Mn
Dec 31, 2025 -25.29 Mn
Sep 30, 2025 -28.24 Mn
Jun 30, 2025 -22.70 Mn
Mar 31, 2025 23.55 Mn
Dec 31, 2024 -13.88 Mn
Sep 30, 2024 -18.35 Mn
Jun 30, 2024 -13.18 Mn
Mar 31, 2024 -12.70 Mn
Dec 31, 2023 -12.42 Mn
Sep 30, 2023 -13.14 Mn
Jun 30, 2023 -11.91 Mn
Mar 31, 2023 12.78 Mn
Dec 31, 2022 -11.95 Mn
Sep 30, 2022 -6.16 Mn
Jun 30, 2022 -5.10 Mn
Mar 31, 2022 7.52 Mn
Dec 31, 2021 -924,328.53
Sep 30, 2021 -10.01 Mn
API Access

Nyxoah Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=NYXH&period=max&api_key=YOUR_API_KEY